查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564996

幽門螺旋桿菌診斷的全球市場

Helicobacter Pylori Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球幽門螺旋桿菌診斷市場預計將達到 9.641 億美元

幽門螺旋桿菌診斷的全球市場預計 2023 年為 6.955 億美元，預計到 2030 年將達到 9.641 億美元，2023-2030 年分析期間複合年成長率為 4.8%。醫院終端用途是本報告分析的細分市場之一，預計複合年成長率為 4.8%，到分析期結束時將達到 4.369 億美元。在分析期間，診斷中心最終用途細分市場的複合年成長率預計為 5.1%。

美國市場預計將達到1.849億美元，中國預計複合年成長率為7.2%。

預計 2023 年美國幽門螺旋桿菌診斷市場規模將達 1.849 億美元。中國作為世界第二大經濟體，預計到 2030 年市場規模將達到 2.1 億美元，2023-2030 年分析期間複合年成長率為 7.2%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 2.6% 和 4.4%。在歐洲，德國的複合年成長率預計為 2.8%。

全球幽門螺旋桿菌診斷市場 - 主要趨勢和促進因素總結

幽門螺旋桿菌診斷藥物對胃健康至關重要嗎？

幽門螺旋桿菌（H. pylori）診斷試劑在胃腸道健康管理中變得越來越重要，但為什麼診斷這種細菌如此重要？幽門螺旋桿菌是一種常見於胃壁的細菌，也是造成多種胃腸道疾病的主要原因，包括胃炎、消化性潰瘍，在某些情況下甚至是胃癌。由於幽門螺旋桿菌可以在胃部嚴酷的酸性環境中生存，因此如果不進行治療，感染可能會持續數年，導致慢性消化系統疾病和長期健康併發症。早期準確的檢測對於防止這些症狀的進展至關重要。

幽門螺旋桿菌病菌感染的診斷非常重要。這是因為幽門螺旋桿菌病菌感染的症狀往往與其他胃腸道疾病相似，如果不進行具體測試很難識別。腹痛、腹脹、噁心和消化不良等症狀是許多消化系統疾病的通用，因此準確的診斷有助於區分幽門螺旋桿菌病菌感染與其他原因。檢測幽門螺旋桿菌的方法有很多種，從血液檢查、糞便檢驗和呼吸檢測等非侵入性方法到內視鏡檢查和切片檢查等侵入性方法。每次檢查的準確性根據具體情況而有所不同，但早期發現是預防嚴重併發症的關鍵。隨著人們越來越認知到幽門螺旋桿菌與嚴重胃腸道疾病之間的關聯，準確的診斷對於有效的治療和管理至關重要。

技術如何改善幽門螺旋桿菌的診斷？

科技的進步大大提高了幽門螺旋桿菌診斷的準確性、速度和便利性，提供了廣泛的選擇，以滿足不同的臨床需求。最重要的創新之一是尿素呼氣測試，它成為檢測幽門螺旋桿菌病菌感染最廣泛使用的非侵入性方法。此測試透過測量患者攝取尿素溶液後呼吸中的碳同位素來進行。當幽門螺旋桿菌存在時，細菌會分解尿素並釋放二氧化碳，可以在您的呼吸中檢測到二氧化碳。這種方法提供了高度準確的結果，對於確認治療前後的感染特別有用，並且是更具侵入性測試的可靠替代方案。

另一個重大進展是糞便抗原檢測，可檢測患者糞便檢體中的幽門螺旋桿菌蛋白。現代糞便抗原檢測靈敏且特異性，為診斷活動性性行為感染提供了方便、非侵入性的選擇。這些測試在無法進行內視鏡檢查和呼吸檢測的領域特別有用，並且由於其經濟性和可及性而擴大在臨床環境中使用。

侵入性檢測方法，例如切片檢查活體組織切片，診斷準確性也在提高。切片檢查技術和分子檢測的進步使得檢測幽門螺旋桿菌的抗生素抗藥性成為可能，指南更有效的治療策略。 PCR（聚合酵素鏈鎖反應）等分子診斷方法可以檢測出使幽門螺旋桿菌對常用抗生素產生抗藥性的特定基因，從而解決因抗藥性菌株而導致治療失敗的挑戰。這些技術突破使得幽門螺旋桿菌診斷更有效，可以更早、更準確地檢測並制定更有針對性的治療計劃。

為什麼幽門螺旋桿菌診斷藥物對公共衛生至關重要？

幽門螺旋桿菌的診斷對於公共衛生至關重要，因為幽門螺旋桿菌廣泛流行並與嚴重的胃腸道疾病有關。據估計，世界上一半以上的人口都感染幽門螺旋桿菌，但許多人仍然無症狀。然而，如果出現症狀，可能會導致嚴重後果，包括慢性胃炎、消化性潰瘍，嚴重時甚至會導致胃癌。世界衛生組織 (WHO) 將幽門螺旋桿菌列為第一類致癌性，因為它與胃癌密切相關，早期檢測對於降低這種致命疾病的發生率至關重要。

定期檢測幽門螺旋桿菌對於胃腸道疾病高風險族群尤其重要，例如幽門螺旋桿菌病菌感染率高或獲得醫療保健機會有限的地區。幽門螺旋桿菌病菌感染的早期診斷和治療可以預防消化性潰瘍的發展，顯著降低胃癌的風險，並改善長期健康結果。這對於醫療資源有限的國家尤其重要，因為胃癌是癌症相關死亡的主要原因之一。

在臨床實踐中，幽門螺旋桿菌的診斷對於治療經常被誤認為其他原因的複發性胃腸道症狀至關重要。患有慢性消化不良、胃炎和潰瘍的患者通常只接受症狀治療，而沒有解決潛在的細菌感染。如果沒有正確的診斷，這些患者可能會繼續出現反覆出現的症狀或隨著時間的推移而出現更嚴重的併發症。準確的檢測有助於臨床醫生根除感染並提供有針對性的治療以防止復發，改善患者的治療效果並降低醫療成本。隨著人們越來越認知到幽門螺旋桿菌在胃病中的作用，診斷正在成為旨在減輕全球胃病負擔的公共衛生舉措的基石。

推動幽門螺旋桿菌診斷市場成長的因素有哪些？

幽門螺旋桿菌診斷市場的成長是由意識的提高、技術的進步以及對胃腸道疾病有效管理的需求不斷成長共同推動的。主要因素之一是人們越來越認知到幽門螺旋桿菌病菌感染與胃癌和消化性潰瘍等嚴重健康問題之間的關聯。隨著越來越多的醫療保健專業人員和公共衛生組織強調早期檢測和治療的重要性，對可靠且易於使用的診斷工具的需求正在迅速增加。在幽門螺旋桿菌病菌感染率高的國家尤其如此，篩檢和早期治療可以顯著降低胃癌的發生率。

技術進步也是推動市場成長的主要因素。非侵入性尿素呼氣測試和高精度糞便抗原測試等創新使幽門螺旋桿菌診斷更加容易和方便，使醫療保健專業人員無需進行侵入性操作篩檢和診斷感染。這些進步使患者更容易接受門診和家用檢測，擴大了診斷服務的範圍，並增加了早期發現的可能性。此外，PCR檢測等分子診斷方法的發展使得能夠檢測出抗生素抗藥性幽門螺旋桿菌，有助於解決日益嚴重的抗治療性問題並提高根除治療的成功率。

抗藥性幽門螺旋桿菌的增加也推動了對更先進診斷方法的需求。由於抗生素抗藥性持續使治療變得複雜，因此在開始治療之前進行能夠檢測抗藥性菌株的測試至關重要。透過識別抗藥性模式，這些診斷可以幫助醫生開出最有效的抗生素，減少治療失敗的機會並防止抗藥性細菌的傳播。隨著醫療保健系統尋求改善治療結果，同時對抗抗生素抗藥性，這種向精準醫療的轉變正在推動診斷市場的成長。

最後，人們對預防醫學的興趣日益濃厚，推動了對幽門螺旋桿菌診斷的需求。許多醫療機構已經實施了針對高風險族群的篩檢計劃，以便在病菌感染導致更嚴重的疾病之前檢測和治療它。這種預防方法不僅可以改善患者的治療效果，還可以降低與晚期胃病治療相關的長期醫療費用。隨著全球醫療保健趨勢繼續優先考慮早期檢測和精準治療，對準確且易於使用的幽門螺旋桿菌診斷的需求不斷增加，使其成為醫療診斷市場的關鍵成長領域。

受訪企業範例（共12家）

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP12332

Global Helicobacter Pylori Diagnostics Market to Reach US$964.1 Million by 2030

The global market for Helicobacter Pylori Diagnostics estimated at US$695.5 Million in the year 2023, is expected to reach US$964.1 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by the end of the analysis period. Growth in the Diagnostics Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$184.9 Million While China is Forecast to Grow at 7.2% CAGR

The Helicobacter Pylori Diagnostics market in the U.S. is estimated at US$184.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$210.0 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Helicobacter Pylori Diagnostics Market - Key Trends and Drivers Summarized

Is Helicobacter Pylori Diagnostics Crucial for Stomach Health?

Helicobacter pylori (H. pylori) diagnostics are becoming increasingly important in the management of gastrointestinal health, but what makes diagnosing this bacteria so critical? H. pylori is a type of bacteria commonly found in the stomach lining and is the leading cause of various gastrointestinal disorders, including gastritis, peptic ulcers, and, in some cases, gastric cancer. Because of its ability to survive in the harsh acidic environment of the stomach, H. pylori infections can persist for years without treatment, leading to chronic digestive issues and long-term health complications. Early and accurate detection is essential to preventing the progression of these conditions.

Diagnosing H. pylori infections is crucial because symptoms can often mimic other gastrointestinal problems, making it difficult to identify without specific tests. Symptoms like abdominal pain, bloating, nausea, and indigestion are common in many digestive disorders, so accurate diagnostics help differentiate H. pylori infections from other causes. Tests for H. pylori range from non-invasive methods, such as blood tests, stool tests, and breath tests, to invasive procedures like endoscopy and biopsy. Each test offers varying degrees of accuracy, depending on the situation, but early detection is key in preventing severe complications. As awareness of H. pylori’s link to serious gastrointestinal diseases grows, the demand for precise diagnostics is becoming more critical to effective treatment and management.

How Has Technology Improved Helicobacter Pylori Diagnostics?

Technological advancements have significantly improved the accuracy, speed, and ease of Helicobacter pylori diagnostics, offering a range of options tailored to different clinical needs. One of the most significant innovations is the urea breath test, which has become one of the most widely used non-invasive methods for detecting H. pylori infections. This test works by measuring carbon isotopes in the breath after a patient ingests a urea solution. If H. pylori is present, the bacteria will break down the urea, releasing carbon dioxide that can be detected in the breath. This method provides highly accurate results and is particularly useful for confirming infection before and after treatment, offering a reliable alternative to more invasive testing.

Another major advancement is in stool antigen testing, which detects H. pylori proteins in a patient's stool sample. Modern stool antigen tests are highly sensitive and specific, offering a convenient, non-invasive option for diagnosing active infections. These tests are particularly valuable in areas where endoscopy or breath tests may not be readily available, and they are increasingly used in clinical settings due to their affordability and accessibility.

Invasive testing methods, such as endoscopy with biopsy, have also seen improvements in diagnostic accuracy. Advances in biopsy techniques and molecular testing now allow for the detection of antibiotic resistance in H. pylori strains, guiding more effective treatment strategies. Molecular diagnostics, such as PCR (polymerase chain reaction), can detect specific genes in H. pylori that confer resistance to commonly used antibiotics, helping to address the rising challenge of treatment failure due to drug-resistant strains. These technological breakthroughs have made H. pylori diagnostics more effective, enabling earlier and more precise detection and better-targeted treatment plans.

Why Are Helicobacter Pylori Diagnostics Essential for Public Health?

H. pylori diagnostics are essential for public health due to the bacteria’s widespread prevalence and its role in severe gastrointestinal diseases. It is estimated that over half of the global population is infected with H. pylori, though many remain asymptomatic. However, for those who do develop symptoms, the consequences can be serious, including chronic gastritis, peptic ulcers, and, in extreme cases, gastric cancer. The World Health Organization (WHO) has classified H. pylori as a Group 1 carcinogen due to its strong link to stomach cancer, making early detection a priority for reducing the incidence of this deadly disease.

Routine testing for H. pylori is particularly important in populations at high risk for gastrointestinal disorders, including regions where H. pylori infection rates are high or where access to healthcare is limited. Diagnosing and treating H. pylori infections early can prevent the development of peptic ulcers and significantly reduce the risk of stomach cancer, improving long-term health outcomes. This is especially important in countries with limited resources, where gastric cancer remains one of the leading causes of cancer-related deaths.

In clinical practice, diagnosing H. pylori is crucial for managing recurrent gastrointestinal symptoms that are often misattributed to other causes. Patients with chronic indigestion, gastritis, or ulcers are often treated symptomatically without addressing the underlying bacterial infection. Without proper diagnostics, these patients may continue to suffer from recurring symptoms or develop more serious complications over time. Accurate testing helps clinicians provide targeted treatments that eradicate the infection and prevent relapses, leading to better patient outcomes and reduced healthcare costs. As awareness of H. pylori's role in gastric diseases grows, diagnostics are becoming a cornerstone of public health initiatives aimed at reducing the global burden of stomach disorders.

What Factors Are Driving the Growth of the Helicobacter Pylori Diagnostics Market?

The growth in the Helicobacter pylori diagnostics market is driven by a combination of rising awareness, technological advancements, and increasing demand for effective management of gastrointestinal disorders. One of the primary drivers is the growing recognition of the link between H. pylori infection and serious health issues such as gastric cancer and peptic ulcers. As more healthcare professionals and public health organizations emphasize the importance of early detection and treatment, the demand for reliable, accessible diagnostic tools has surged. This is particularly true in countries with high H. pylori infection rates, where screening and early treatment can significantly reduce the incidence of gastric cancer.

Technological advancements are another major factor propelling market growth. Innovations such as non-invasive urea breath tests and highly accurate stool antigen tests have made H. pylori diagnostics more accessible and convenient, allowing healthcare providers to screen and diagnose infections without the need for invasive procedures. These advancements have made it easier for patients to be tested in outpatient or even home settings, broadening the reach of diagnostic services and increasing the likelihood of early detection. In addition, the development of molecular diagnostics, such as PCR tests, allows for the detection of antibiotic-resistant H. pylori strains, helping to combat the growing problem of treatment resistance and improve the success rates of eradication therapies.

The increasing prevalence of drug-resistant H. pylori strains is also driving demand for more advanced diagnostics. As antibiotic resistance continues to complicate treatment, the need for tests that can detect resistant strains before treatment is initiated has become critical. By identifying resistance patterns, these diagnostics help physicians prescribe the most effective antibiotics, reducing the likelihood of treatment failure and preventing the spread of resistant bacteria. This shift toward precision medicine is driving growth in the diagnostics market as healthcare systems seek to improve treatment outcomes while combating antibiotic resistance.

Lastly, the growing focus on preventive healthcare is pushing the demand for H. pylori diagnostics. Many health systems are adopting screening programs aimed at high-risk populations to detect and treat H. pylori infections before they lead to more severe diseases. This preventive approach not only improves patient outcomes but also reduces the long-term healthcare costs associated with treating advanced gastric diseases. As global healthcare trends continue to prioritize early detection and precision treatment, the demand for accurate and accessible H. pylori diagnostics is set to rise, making it a critical area of growth in the medical diagnostics market.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Helicobacter Pylori Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Helicobacter Pylori Infections Drives Demand for Diagnostic Solutions
    • Growth in Gastrointestinal Disease Screening Expands Addressable Market for H. Pylori Diagnostics
    • Increasing Focus on Early Detection and Treatment of Peptic Ulcers Spurs Adoption of H. Pylori Testing
    • Growth in Use of Urea Breath Tests (UBT) for Non-invasive H. Pylori Detection Drives Adoption
    • Increasing Demand for Point-of-care Testing Solutions Expands Market for H. Pylori Diagnostics
    • Expansion of Diagnostic Laboratories and Healthcare Facilities Boosts Availability of H. Pylori Testing
    • Market Dynamics Driven by Rising Prevalence of Antibiotic-resistant Strains of H. Pylori
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Helicobacter Pylori Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • JAPAN
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • CHINA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • EUROPE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • FRANCE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • GERMANY
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • INDIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • AFRICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030

IV. COMPETITION